India Pharma Outlook Team | Monday, 08 September 2025
In this modern age of Artificial Intelligence, it is important to provide the new age AI driven solutions to the society in the healthcare sector also. In a strategic move to strengthen healthcare innovation in India, Ms. Pallavi Mehta, MD of women driven startup Mc&Me Techserve Pvt. Ltd has signed an MOU with Stefan Voser of Emeralgo, AI driven software company Computer Vision AG of Switzerland.
As part of the collaboration, the partners will invest approximately €25 million (INR ~225 crores) in setting up an R&D and Data Center project in India. The investment will be structured with Party A contributing 76% and Party B contributing 24%. The venture is projected to generate revenues of around INR 300 crores by the third year of operations, with expected growth of 30% year-on-year thereafter.
Key highlights of the Joint Venture include:
software for hospitals and diagnostic centers in India.
Speaking on the collaboration, Stefan Voser, COO, Emeralgo AI said:
“This investment reflects our confidence in India’s healthcare sector and our commitment to making AI-driven diagnostics more accessible and impactful.”
Also Read: Eli Lilly Wins USFDA Breakthrough for Olomorasib in Lung Cancer Therapy
Pallavi Mehta, Managing Director, Mc&Me Techserve Pvt Ltd added:
“Together, we will not only deliver cutting-edge healthcare solutions but also create jobs, empower rural communities, and make healthcare more affordable for the underprivileged. ”
The joint venture is expected to significantly boost the adoption of AI in Indian healthcare, improving accuracy, speed, and reach of diagnostic services.